LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems presented publicly the first pre-clinical results of its research demonstrating the FLASH effect using a commercial MEVION S250i proton ...

LITTLETON, Mass.--(BUSINESS WIRE)--At the first virtual meeting of the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, October 23rd to the 29th, Mevion will highlight its research ...

RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop advanced treatment planning techniques for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At the American Society for Radiation Oncology meeting in ...

The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs LITTLETON, Mass., May 11, 2026--(BUSINESS WIRE)--Proton therapy ...

Mevion Medical Systems has partnered with Nebraska Medicine to install a proton therapy system at the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska, US. The MEVION S250-FIT proton therapy ...

Stanford Medicine Cancer Center delivers the world’s first patient treatment using an ultra-compact proton therapy system installed in an existing conventional radiation therapy vault Mevion Medical ...

CE Marking enables marketing and clinical use of the world's first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact ...

LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO2021—RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop ...

Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, ...